Cabaletta Bio, Inc. 8-K

What Happened

• Cabaletta Bio, Inc. announced its financial results for the quarter ended March 31, 2026 and furnished the related press release on Form 8-K filed on May 14, 2026 (Item 2.02). The press release is provided as Exhibit 99.1 to the filing. The report was signed by Steven Nichtberger, Chief Executive Officer and President.

Key Details

• Filing date: May 14, 2026 (Form 8-K, Item 2.02 and Item 9.01).
• Reporting period: Quarter ended March 31, 2026.
• Disclosure format: Press release furnished as Exhibit 99.1; interactive XBRL cover page included.
• Authorized signatory: Steven Nichtberger, CEO and President.

Why It Matters

• This 8-K furnishes Cabaletta’s latest quarterly results and information about the company’s financial condition, which investors use to assess recent performance (earnings, revenue, expenses, cash position). Review the furnished press release (Exhibit 99.1) for the specific financial figures and management commentary.